Seminoma epidemiology and demographics: Difference between revisions
(→Age) |
|||
(22 intermediate revisions by 3 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Seminoma}} | {{Seminoma}} | ||
{{CMG}}{{AE}}{{ | {{CMG}}{{AE}}{{S.G.}} | ||
==Overview== | ==Overview== | ||
The [[incidence]] of testicular cancer is approximately 5.7 per 100,000 men per year based on 2011-2015 report in the United States. [[Testicular]] [[cancer]] is the most common type of cancer in young males. [[Germ cell tumors]] are about 98% of [[testicular]] [[cancer]]. About 55% of [[germ cell tumors]] are seminomas.The prevalence of [[testicular]] [[cancer]] is estimated to be 9,310 new cases in 2018. Seminoma commonly affects individuals young adults 15 and 35 years of age. Seminoma is usually first diagnosed among 34 years (median, 39.5 years). The majority of seminoma cases are reported in Europe, Scandinavia and North America. | |||
==Epidemiology== | ==Epidemiology== | ||
===Incidence=== | |||
*The [[incidence]] of testicular cancer is approximately 5.7 per 100,000 men per year based on 2011-2015 report in the United States.<ref name="urlTesticular Cancer - Cancer Stat Facts">{{cite web |url=https://seer.cancer.gov/statfacts/html/testis.html |title=Testicular Cancer - Cancer Stat Facts |format= |work= |accessdate=}}</ref> | |||
===Prevalence=== | ===Prevalence=== | ||
*Testicular | *[[Testicular]] [[cancer]] is the most common type of cancer in young males.<ref name="pmid242041712">{{cite journal |vauthors=Shanmugalingam T, Soultati A, Chowdhury S, Rudman S, Van Hemelrijck M |title=Global incidence and outcome of testicular cancer |journal=Clin Epidemiol |volume=5 |issue= |pages=417–27 |date=October 2013 |pmid=24204171 |pmc=3804606 |doi=10.2147/CLEP.S34430 |url=https://dx.doi.org/10.2147/CLEP.S34430}}</ref><ref name="pmid30620402">{{cite journal |vauthors=Siegel RL, Miller KD, Jemal A |title=Cancer statistics, 2019 |journal=CA Cancer J Clin |volume=69 |issue=1 |pages=7–34 |date=January 2019 |pmid=30620402 |doi=10.3322/caac.21551 |url=}}</ref> | ||
*[[Germ cell tumors]] are about 98% of [[testicular]] [[cancer]].<ref name="pmid20447912">{{cite journal |vauthors=Chia VM, Quraishi SM, Devesa SS, Purdue MP, Cook MB, McGlynn KA |title=International trends in the incidence of testicular cancer, 1973-2002 |journal=Cancer Epidemiol. Biomarkers Prev. |volume=19 |issue=5 |pages=1151–9 |date=May 2010 |pmid=20447912 |pmc=2867073 |doi=10.1158/1055-9965.EPI-10-0031 |url=}}</ref> | |||
**About 55% of [[germ cell tumors]] are seminomas | |||
*The prevalence of [[testicular]] [[cancer]] is estimated to be 9,310 new cases in 2018.<ref name="urlTesticular Cancer - Cancer Stat Facts">{{cite web |url=https://seer.cancer.gov/statfacts/html/testis.html |title=Testicular Cancer - Cancer Stat Facts |format= |work= |accessdate=}}</ref> | |||
===Age=== | ===Age=== | ||
*Seminoma commonly affects individuals young adults 15 and 35 years of age.<ref name="CheTamboli2002">{{cite journal|last1=Che|first1=Mingxin|last2=Tamboli|first2=Pheroze|last3=Ro|first3=Jae Y.|last4=Park|first4=Dong Soo|last5=Ro|first5=Jung Sil|last6=Amato|first6=Robert J.|last7=Ayala|first7=Alberto G.|title=Bilateral testicular germ cell tumors|journal=Cancer|volume=95|issue=6|year=2002|pages=1228–1233|issn=0008-543X|doi=10.1002/cncr.10804}}</ref> | |||
*Seminoma is usually first diagnosed among 34 years (median, 39.5 years).<ref name="pmid27184033">{{cite journal |vauthors=Di Gregorio M, Nollevaux MC, Lorge F, D'Hondt L |title=Metachronous testicular seminoma after radiotherapy and chemotherapy: a case report |journal=World J Surg Oncol |volume=14 |issue= |pages=147 |date=May 2016 |pmid=27184033 |pmc=4867539 |doi=10.1186/s12957-016-0902-9 |url=}}</ref> | |||
===Race=== | ===Race=== | ||
*Seminoma usually affects individuals of the white race. Black individuals are less likely to develop seminoma (ratio of 5 : 1).<ref name="pmid19903067">{{cite journal |vauthors=McGlynn KA, Cook MB |title=Etiologic factors in testicular germ-cell tumors |journal=Future Oncol |volume=5 |issue=9 |pages=1389–402 |date=November 2009 |pmid=19903067 |pmc=3000220 |doi=10.2217/fon.09.116 |url=}}</ref> | |||
===Gender=== | |||
*Seminoma affects exclusively in men. | |||
===Region=== | |||
*The majority of seminoma cases are reported in Europe, Scandinavia and North America.<ref name="pmid24204171">{{cite journal |vauthors=Shanmugalingam T, Soultati A, Chowdhury S, Rudman S, Van Hemelrijck M |title=Global incidence and outcome of testicular cancer |journal=Clin Epidemiol |volume=5 |issue= |pages=417–27 |date=October 2013 |pmid=24204171 |pmc=3804606 |doi=10.2147/CLEP.S34430 |url=}}</ref> | |||
==References== | ==References== | ||
Line 25: | Line 37: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Urology]] |
Latest revision as of 13:33, 15 May 2019
Seminoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Seminoma epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Seminoma epidemiology and demographics |
Risk calculators and risk factors for Seminoma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sogand Goudarzi, MD [2]
Overview
The incidence of testicular cancer is approximately 5.7 per 100,000 men per year based on 2011-2015 report in the United States. Testicular cancer is the most common type of cancer in young males. Germ cell tumors are about 98% of testicular cancer. About 55% of germ cell tumors are seminomas.The prevalence of testicular cancer is estimated to be 9,310 new cases in 2018. Seminoma commonly affects individuals young adults 15 and 35 years of age. Seminoma is usually first diagnosed among 34 years (median, 39.5 years). The majority of seminoma cases are reported in Europe, Scandinavia and North America.
Epidemiology
Incidence
- The incidence of testicular cancer is approximately 5.7 per 100,000 men per year based on 2011-2015 report in the United States.[1]
Prevalence
- Testicular cancer is the most common type of cancer in young males.[2][3]
- Germ cell tumors are about 98% of testicular cancer.[4]
- About 55% of germ cell tumors are seminomas
- The prevalence of testicular cancer is estimated to be 9,310 new cases in 2018.[1]
Age
- Seminoma commonly affects individuals young adults 15 and 35 years of age.[5]
- Seminoma is usually first diagnosed among 34 years (median, 39.5 years).[6]
Race
- Seminoma usually affects individuals of the white race. Black individuals are less likely to develop seminoma (ratio of 5 : 1).[7]
Gender
- Seminoma affects exclusively in men.
Region
- The majority of seminoma cases are reported in Europe, Scandinavia and North America.[8]
References
- ↑ 1.0 1.1 "Testicular Cancer - Cancer Stat Facts".
- ↑ Shanmugalingam T, Soultati A, Chowdhury S, Rudman S, Van Hemelrijck M (October 2013). "Global incidence and outcome of testicular cancer". Clin Epidemiol. 5: 417–27. doi:10.2147/CLEP.S34430. PMC 3804606. PMID 24204171.
- ↑ Siegel RL, Miller KD, Jemal A (January 2019). "Cancer statistics, 2019". CA Cancer J Clin. 69 (1): 7–34. doi:10.3322/caac.21551. PMID 30620402.
- ↑ Chia VM, Quraishi SM, Devesa SS, Purdue MP, Cook MB, McGlynn KA (May 2010). "International trends in the incidence of testicular cancer, 1973-2002". Cancer Epidemiol. Biomarkers Prev. 19 (5): 1151–9. doi:10.1158/1055-9965.EPI-10-0031. PMC 2867073. PMID 20447912.
- ↑ Che, Mingxin; Tamboli, Pheroze; Ro, Jae Y.; Park, Dong Soo; Ro, Jung Sil; Amato, Robert J.; Ayala, Alberto G. (2002). "Bilateral testicular germ cell tumors". Cancer. 95 (6): 1228–1233. doi:10.1002/cncr.10804. ISSN 0008-543X.
- ↑ Di Gregorio M, Nollevaux MC, Lorge F, D'Hondt L (May 2016). "Metachronous testicular seminoma after radiotherapy and chemotherapy: a case report". World J Surg Oncol. 14: 147. doi:10.1186/s12957-016-0902-9. PMC 4867539. PMID 27184033.
- ↑ McGlynn KA, Cook MB (November 2009). "Etiologic factors in testicular germ-cell tumors". Future Oncol. 5 (9): 1389–402. doi:10.2217/fon.09.116. PMC 3000220. PMID 19903067.
- ↑ Shanmugalingam T, Soultati A, Chowdhury S, Rudman S, Van Hemelrijck M (October 2013). "Global incidence and outcome of testicular cancer". Clin Epidemiol. 5: 417–27. doi:10.2147/CLEP.S34430. PMC 3804606. PMID 24204171.